River BioMedics - Closer to the Heart
River BioMedics develops 3D human heart models based on stem cell technology that are able to mimic the pumping function of the human heart. We have validated our models with a set of drugs known to affect the heart, and aim to sell the use of these models to pharmaceutical companies for them to develop their new drugs in exchange for upfront and milestone payments. We envision to revolutionize drug discovery!
Together with Marcelo Ribeiro (CEO/CSO) and Robert Passier (scientific advisor), Lisanne is co-founder of River BioMedics. She is currently working as a business developer for the start-up company. Lisanne did her PhD research in Leiden at the department of Medicine division of Endocrinology of the Leiden University Medical Center (LUMC), where she studied genetic determinants of cardiovascular disease. Currently, she is holding a Postdoc position at this department. Her background is in Medicine (BSc, LUMC), and at the moment she is finishing the last year of her Master’s degree in Biomedical Engineering at Delft University of Technology.
Are you a CEO or an investor and interested to network with high level delegates during our special VIP CEO-Investor evening programme and dinner? Book your tickets now!
The teaser of Innovation for Health 2019 is online now, including highlights of keynote speakers, sessions and themes.
Watch the new teaser film of Innovation for Health to get an impression of what you can expect.
Like what you see? Share it via social media and get a discount of €50 on your registration fee.
Watch the teaser
An exciting part of the programme is the yearly start-up pitch contest. Ten start-up companies will get the opportunity to pitch their company and healthcare innovation to key players and decision makers in Health & Life sciences sector on 14 February at Innovation for Health and Global Investor Forum! Find out who is selected to compete in the yearly start-up pitch contest!
Check it here!
© 2019 Innovation for Health